Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Allergen or component thereof
Patent
1978-01-30
1978-12-19
Randolph, John D.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Allergen or component thereof
260327B, A61K 31385, C07D33712
Patent
active
041306546
ABSTRACT:
This invention relates to novel 4-(8X-6,11-dihydrodibenzo-[b.e.]-thiepin-11-one-3-yl)-4-oxobutyric acids and their derivatives, wherein X is hydrogen, methoxy or chloro, methods of preparation, compositions and uses thereof.
REFERENCES:
patent: 3989839 (1976-11-01), Ackrell
patent: 4000288 (1976-12-01), Ackrell
patent: 4000308 (1976-12-01), Ackrell
patent: 4025640 (1977-05-01), McFadden et al.
patent: 4051148 (1977-09-01), Prince et al.
patent: 4051149 (1977-09-01), Ackrell
patent: 4051150 (1977-09-01), Kluge
patent: 4052412 (1977-10-01), Bastian
patent: 4055574 (1977-10-01), Ackrell et al.
patent: 4064141 (1977-12-01), Ackrell
Rajsner et al., Chem. Abstracts, vol. 79, abst. 78586w (1973).
Blaufarb Gerard A.
Randolph John D.
Syntex (U.S.A.) Inc.
LandOfFree
Novel 4-(8X-6,11-dihydrodibenzo-[b.e.]-thiepin-11-one-3-yl)-4-ox does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel 4-(8X-6,11-dihydrodibenzo-[b.e.]-thiepin-11-one-3-yl)-4-ox, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel 4-(8X-6,11-dihydrodibenzo-[b.e.]-thiepin-11-one-3-yl)-4-ox will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2373830